Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psychopathology and endorphins

G C Davis, W E Bunney

    Advances in Biochemical Psychopharmacology
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Endorphins may play a role in schizophrenia, with some evidence suggesting their involvement in affective disorders. Further research into endorphins and psychomotor functions is warranted.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Electrophysiological evaluation of extracellular spermine and alkaline pH on synaptic human GABA<sub>A</sub> receptors.

    Translational psychiatry·2019
    Same author

    Quantitative validation of immunofluorescence and lectin staining using reduced CLARITY acrylamide formulations.

    Brain structure & function·2017
    Same author

    Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder.

    Translational psychiatry·2016
    Same author

    Functional brain imaging, sleep, and sleep deprivation: contributions to the "overarousal" hypothesis of depression.

    Acta neuropsychiatrica·2016
    Same author

    Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder.

    Translational psychiatry·2015
    Same author

    Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin.

    Molecular psychiatry·2015
    Same journal

    Toward a temperament-based approach to depression: implications for neurobiologic research.

    Advances in biochemical psychopharmacology·1995
    Same journal

    Recent developments in genetics of bipolar illness.

    Advances in biochemical psychopharmacology·1995
    Same journal

    Manipulation of inositol-linked second messenger systems as a therapeutic strategy in psychiatry.

    Advances in biochemical psychopharmacology·1995
    Same journal

    Animal models of mania.

    Advances in biochemical psychopharmacology·1995
    Same journal

    Animal models of depression: validity and applications.

    Advances in biochemical psychopharmacology·1995
    Same journal

    The long term prophylaxis of affective disorders.

    Advances in biochemical psychopharmacology·1995
    See all related articles

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Endocrinology

    Background:

    • Endorphins, endogenous opioids, are implicated in pain perception and mood regulation.
    • Suggestive evidence links endorphins to schizophrenia, with some patients showing elevated cerebrospinal fluid (CSF) opiate-binding substances.
    • Research on endorphins in affective disorders is less extensive.

    Purpose of the Study:

    • To explore the potential link between endorphins and schizophrenia.
    • To investigate the role of endorphins in affective illnesses, including depression and mania.
    • To identify promising areas for future research, such as catatonic symptoms and psychomotor functions.

    Main Methods:

    • Review of existing literature on endorphins and psychiatric syndromes.

    Related Experiment Videos

  • Analysis of studies using narcotic antagonists to treat schizophrenic symptoms.
  • Examination of CSF endorphin levels in patients with schizophrenia, affective disorders, and depression.

    • Main Results:

    • Narcotic antagonists show potential in attenuating some schizophrenic symptoms and improving attentional performance.
    • Elevated CSF opiate-binding substances are observed in a subgroup of schizophrenic patients.
    • CSF endorphins appear elevated in some patients with manic-depressive illness and in pain patients with depression.

    Conclusions:

    • Endorphins represent a potential therapeutic target for schizophrenia.
    • Further investigation is needed to clarify the role of endorphins in affective disorders, particularly mania.
    • Catatonic symptoms and other psychomotor functions are promising areas for future research on endorphin involvement.